Carmel Pharma

Columbus, United States Founded: 1994 • Age: 32 yrs Acquired By Becton Dickinson
Closed-system transfer devices are produced for safe hazardous drug handling.

About Carmel Pharma

Carmel Pharma is a company based in Columbus (United States) founded in 1994 was acquired by Becton Dickinson in July 2011.. Carmel Pharma has raised $2.56 million across 2 funding rounds from investors including BD and 3i Group. Carmel Pharma operates in a competitive market with competitors including ICU Medical, Equashield, Corvida Medical and Simplivia, among others.

  • Headquarter Columbus, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Carmel Pharma Inc
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.56 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    BD

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Becton Dickinson

    (Jul 27, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Carmel Pharma

Carmel Pharma has successfully raised a total of $2.56M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (01 Jan 1999)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Dec, 2005 Amount Private Equity Round - Carmel Pharma Valuation 3i Group
Jan, 1999 Amount Series A - Carmel Pharma Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Carmel Pharma

Carmel Pharma has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include BD and 3i Group. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity firm focused on mid-market businesses
Founded Year Domain Location
BD is recognized for providing innovative medical technology solutions.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Carmel Pharma

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Carmel Pharma

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Carmel Pharma Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Carmel Pharma

Carmel Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as ICU Medical, Equashield, Corvida Medical and Simplivia, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Drug and Infusion delivery devices
domain founded_year HQ Location
Closed-system transfer devices for hazardous drug handling are developed.
domain founded_year HQ Location
Closed system transfer device for safe administration of hazardous drugs
domain founded_year HQ Location
Manufactures closed system transfer devices to protect healthcare workers from drug exposure.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Carmel Pharma

Frequently Asked Questions about Carmel Pharma

When was Carmel Pharma founded?

Carmel Pharma was founded in 1994 and raised its 1st funding round 5 years after it was founded.

Where is Carmel Pharma located?

Carmel Pharma is headquartered in Columbus, United States. It is registered at Columbus, Ohio, United States.

Is Carmel Pharma a funded company?

Carmel Pharma is a funded company, having raised a total of $2.56M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.56M, raised on Jan 01, 1999.

What does Carmel Pharma do?

Founded in 1994 and based in Columbus, United States, Carmel Pharma operates in the medical device sector, focusing on the PhaSeal System, an FDA-approved closed-system transfer device. This system is utilized by healthcare providers in hospitals for managing hazardous drugs, with implementations across cancer centers, oncology practices, and specialty pharmacies in the United States, Europe, and Asia. Acquisition by Becton-Dickinson occurred in 2011.

Who are the top competitors of Carmel Pharma?

Carmel Pharma's top competitors include Equashield, ICU Medical and Corvida Medical.

Who are Carmel Pharma's investors?

Carmel Pharma has 2 investors. Key investors include BD, and 3i Group.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available